Supplementary Figure 1 Identification of CMV-neutralizating antibodies by hybridoma screening. (A) Supernatants from ~2000 murine hybridomas were tested for their ability to neutralize CMV infection of MRC5 fibroblasts with AD169IE2-YFP following preincubation with virus. All samples were normalized as %infection compared to the median value for all samples. The dotted line represents the 50% infection cutoff used to select hybridomas for further screening. (B) Hybridoma supernatants from the clones that reduced infection by 50% were screened at 100%, 60%, or 10% hybridoma supernatant concentration and normalized to the median of all samples tested.
Supplementary Figure 5 Anti-gH monoclonal antibodies limit viral dissemination following virus infection. MRC5 cells infected (moi: 0.1) with AD169 IE2/YFP were treated with isotype, Cytogam, 10C10, and 5C3 (0.5μg/ml) at 24 hpi for up to 6 days. The cells were visualized (2X objective) using phasecontrast and fluorescence microscopy. A plaque was identified as a cluster of infected cells. The phase contrast and fluorescence signal were overlayed to identify a plaque and the number of infected cells within a plaque. Scale bar = 500 micron. The data demonstrates significant cytopathogenicity in the isotype antibody-treated cells and numerous virus infected cells/plaque. In contrast, treating cells with anti-CMV antibodies showed a decrease in cytopathogenicity suggesting an inhibition in viral dissemination. Infected cells treated with the anti-gH mAbs 10C10 and 5C3 demonstrated a decrease in both plaque number and virusinfected cells/plaque when compared to the Cytogam treated infected cells. , and U373gH/gL/gO-HA (Lanes 31-40) cells were exposed to 10C10 or 5C3 at various concentrations (0.1-2μg/mL) and the resolved immune complexes were exposed to gH immunoblot. Densitometry values of the recovered gH are depicted (right column). (B) TB40/E virus prep was incubated with varying concentration of mAb 10C10 and 5C3 (0.1-4μg/mL). Virus/mAb complexes were then recovered by ultracentrifugation and total protein was resolved by SDS-PAGE, followed by immunoblot for anti-mouse heavy and light chain (Lanes 1-12) or Cytogam® (Lanes 13-24). IgG and pp65 are indicated by arrows. Average densitometry values of the pp65:IgG ratio from 3 independent experiments are depicted (right column) with standard deviation. and 5C3 647 (4μg/ml) with increasing concentrations of non-conjugated isotype, 10C10, 5C3, or 14-4b (0.2, 0.7, 2.1, and 7.0μg/mL) (in triplicate). The fluorescence signal from the labeled U373 gH/gL cells was measured by flow cytometry. The % binding was determined using the mean fluorescence intensity measured from the corresponding isotype concentration as 100%. , and pre-incubated with AD169IE2-YFP at multiple concentrations (.02-12μg/mL for each respective antibody). (C) Antibody cocktails containing 1μg/mL of Cytogam® with 1μg/mL of an isotype control, or Cytogam® with mAb 5C3 were tested for their ability to neutralize TB40/EFLAG-YFP infection of ARPE-19 cells. Experiments were performed in technical triplicate. Standard deviation is depicted for all experiments. * = p<0.05 (student's 2-tailed t test)
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